These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
532 related articles for article (PubMed ID: 7228455)
21. Study of bioavailability and pharmacokinetics of theophylline following administration of two sustained release dosage forms as assessed by salivary data: Part II. Ohmori N; Inotsume N; Matsukura M; Higashi A; Iwaoku R; Tobino Y; Nakano M; Matsuda I Int J Clin Pharmacol Ther Toxicol; 1986 Apr; 24(4):196-201. PubMed ID: 3710632 [TBL] [Abstract][Full Text] [Related]
22. A comparison of steady state plasma theophylline concentrations with conventional and sustained release formulations. Mellstrand T; Svedmyr K; Svedmyr N Eur J Respir Dis; 1982 Jan; 63(1):31-4. PubMed ID: 7040098 [TBL] [Abstract][Full Text] [Related]
23. Comparative steady-state bioavailability of Theo-24 and Theo-Dur in healthy men. Dockhorn RJ; Cefali EA; Straughn AB Ann Allergy; 1994 Mar; 72(3):218-22. PubMed ID: 8129214 [TBL] [Abstract][Full Text] [Related]
24. [Release, absorption and elimination of theophylline from fast and slowly released oral formulations]. Frömming KH; Schwabe L; Staib AH; Rietbrock N; Lassmann A; Molz KH; Schuppan D; Siebert-Weigel M; Voegele D Arzneimittelforschung; 1983; 33(3):446-52. PubMed ID: 6683521 [TBL] [Abstract][Full Text] [Related]
25. Effect of sustained-release on the pharmacokinetics of theophylline in healthy subjects. Bialer M; Salame K; Raz I Int J Clin Pharmacol Ther Toxicol; 1985 Dec; 23(12):662-7. PubMed ID: 4093206 [TBL] [Abstract][Full Text] [Related]
26. [Comparison of circadian variation of serum theophylline concentration and bioavailability between Theo-dur tablet and a new sustained-release theophylline formulation (E-0686 granule)]. Kishida M; Okuma M; Uekusa T; Akimoto K; Obata T; Akazawa A; Odajima Y; Nagakura T; Iikura Y; Hukushima K Arerugi; 1988 Apr; 37(4):218-25. PubMed ID: 3228360 [No Abstract] [Full Text] [Related]
27. Comparison of steady state serum theophylline concentrations in healthy volunteers after dosing with Euphyllin retard and PulmiDur. Karlsson S; Lührmann B; Bahner ML; Schulz HU Int J Clin Pharmacol Ther Toxicol; 1987 Jun; 25(6):342-6. PubMed ID: 3623739 [TBL] [Abstract][Full Text] [Related]
31. Bioavailability of sustained-release theophylline formulations. Bonora Regazzi M; Rondanelli R; Vidale E; Cristiani D Int J Clin Pharmacol Ther Toxicol; 1983 May; 21(5):245-51. PubMed ID: 6862729 [TBL] [Abstract][Full Text] [Related]
32. Therapeutic equivalence of a generic slow-release theophylline tablet. Hendeles L; Breton AL; Beaty R; Harman E Pharmacotherapy; 1995; 15(1):26-35. PubMed ID: 7739942 [TBL] [Abstract][Full Text] [Related]
33. Evaluation of the effect of 3 different diets on the bioavailability of 2 sustained release theophylline matrix tablets. Gai MN; Isla A; Andonaegui MT; Thielemann AM; Seitz C Int J Clin Pharmacol Ther; 1997 Dec; 35(12):565-71. PubMed ID: 9455715 [TBL] [Abstract][Full Text] [Related]
34. Comparative absorption of theophylline following multiple doses of a sustained-release formulation and an elixir in humans. Harrison LI; French IW; Mildon CA Clin Ther; 1982; 4(6):489-96. PubMed ID: 7093982 [TBL] [Abstract][Full Text] [Related]
35. Conversion from intravenous to oral dosing using sustained-release theophylline tablets. Stein GE; Haughey DB; Ross RJ; Vakoutis J Drug Intell Clin Pharm; 1982 Oct; 16(10):772-4. PubMed ID: 7140514 [TBL] [Abstract][Full Text] [Related]
36. Absorption properties of two theophylline sustained-release products in smokers. Miller R; Rheeders M S Afr Med J; 1984 Jun; 65(26):1045-8. PubMed ID: 6740419 [TBL] [Abstract][Full Text] [Related]
37. [Pharmacokinetics of theophylline. Repeated single evening administration of Pulmo-Timelets slow-release capsules in comparison with theophylline slow-release tablets]. Heusinger JH; Breuel HP; Behrendt WA; Wolfstädter HD Fortschr Med; 1989 Nov; 107(32):692-6. PubMed ID: 2689314 [TBL] [Abstract][Full Text] [Related]
38. [Bioavailability of theophylline in a new oral sustained-release preparation (author's transl)]. Schneider GF; Heese GU; Huber HJ; Janzen N; Jünger H; Moser C; Stanislaus F Arzneimittelforschung; 1981; 31(9):1489-97. PubMed ID: 7197962 [TBL] [Abstract][Full Text] [Related]
39. A cross-over study of oral and intravenous administration of theophylline in male volunteers. Absolute bioavailability of theophylline tablets. Kaumeier HS; Kehrhahn OH; Neugebauer G; Schuppan D; Schwarz JA; Staib AH Arzneimittelforschung; 1984; 34(1):92-5. PubMed ID: 6538428 [TBL] [Abstract][Full Text] [Related]
40. [Absorption profile and absolute bioavailability of a theophylline sustained-release preparation]. Pabst G; Weber W; Barkworth MF; Müller M; Rehm KD Arzneimittelforschung; 1998 May; 48(5A):574-9. PubMed ID: 9676347 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]